Moderna | Hisse Başına Kazanç



Fiscal Takvim Gerçek Fikir Birliği Önceki Tarih
FY2025Q1 Mar/2025 -2.52 -3.03 -3.07 May/01 2025
FY2024Q4 Dec/2024 -2.91 -2.73 0.55 Feb/14 2025
FY2024Q3 Sep/2024 0.03 -1.92 -9.53 Nov/07 2024
FY2024Q2 Jun/2024 -3.33 -3.35 -3.62 Aug/01 2024
FY2024Q1 Mar/2024 -3.07 -3.55 0.19 May/02 2024
FY2023Q4 Dec/2023 0.55 -0.99 3.61 Feb/22 2024
FY2023Q3 Sep/2023 -9.53 -1.90 2.53 Nov/02 2023
FY2023Q2 Jun/2023 -3.62 -4.11 5.24 Aug/03 2023
FY2023Q1 Mar/2023 0.19 -1.66 8.58 May/04 2023
FY2022Q4 Dec/2022 3.61 4.57 11.29 Feb/23 2023
FY2022Q3 Sep/2022 2.53 2.47 7.7 Nov/03 2022
FY2022Q2 Jun/2022 5.24 4.44 6.46 Aug/03 2022

Eps Değişiklik Tarih
Acadia Pharmaceuticals USD 0.86 0.66 2024-12
Adcock Ingram Holdings ZAR 2.59 0.17 2024-12
Agios Pharmaceuticals USD -1.55 0.11 2025-03
Alnylam Pharmaceuticals USD -0.01 0.64 2025-03
Amgen USD 4.9 0.41 2025-03
Arrowhead Research USD -1.39 0.02 2024-12
Biogen USD 3.02 0.42 2025-03
BioMarin Pharmaceutical USD 1.13 0.49 2025-03
Celltrion KRW 395.45 36.4 2024-09
Cspc Pharmaceutical CNY 0.05 0.02 2024-12
Dianthus Therapeutics USD -0.81 0.07 2024-12
Gilead Sciences USD 1.81 0.09 2025-03
GlaxoSmithKline GBP 0.45 0.22 2025-03
Incyte USD 1.16 0.27 2025-03
Ionis Pharmaceuticals USD -0.93 0.27 2025-03
Kangmei Pharma CNY 0 0 2024-09
Knight Therapeutics CAD 0 0.02 2024-09
Laboratorios Farma 1.81 1.26 2024-12
Malin Corporation 0 0 2024-12
Moderna USD -2.52 0.39 2025-03
Organigram Holdings CAD -0.2 0.12 2024-12
Pharma Mar EUR -0.23 1.31 2025-03
Qiagen NV USD 0.59 0.06 2024-12
Regeneron Pharmaceuticals USD 8.22 3.85 2025-03
Sarepta Therapeutics USD 1.5 1.16 2024-12
Sartorius EUR 1.22 0.18 2025-03
Sino Biopharmaceutical CNY 0.03 0.05 2024-12
Tilray USD -1.24 1.14 2025-03
Ultragenyx Pharmaceutical USD -1.39 0.01 2024-12
United Therapeutics USD 6.63 0.44 2025-03
Vertex Pharmaceuticals USD 3.98 0.4 2024-12
Zhangzhou Pientzehuang Pharmaceutical 1.66 1.18 2025-03



Moderna Hisse Başına Kazanç - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - May 2025.